207 related articles for article (PubMed ID: 20888920)
1. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers.
Liang WS; Chen K; Lee W; Sidhar K; Corneveaux JJ; Allen AN; Myers A; Villa S; Meechoovet B; Pruzin J; Bandy D; Fleisher AS; Langbaum JB; Huentelman MJ; Jensen K; Dunckley T; Caselli RJ; Kaib S; Reiman EM
Neuroimage; 2011 Feb; 54(3):1896-902. PubMed ID: 20888920
[TBL] [Abstract][Full Text] [Related]
2. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
[TBL] [Abstract][Full Text] [Related]
3. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
5. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
Reiman EM; Webster JA; Myers AJ; Hardy J; Dunckley T; Zismann VL; Joshipura KD; Pearson JV; Hu-Lince D; Huentelman MJ; Craig DW; Coon KD; Liang WS; Herbert RH; Beach T; Rohrer KC; Zhao AS; Leung D; Bryden L; Marlowe L; Kaleem M; Mastroeni D; Grover A; Heward CB; Ravid R; Rogers J; Hutton ML; Melquist S; Petersen RC; Alexander GE; Caselli RJ; Kukull W; Papassotiropoulos A; Stephan DA
Neuron; 2007 Jun; 54(5):713-20. PubMed ID: 17553421
[TBL] [Abstract][Full Text] [Related]
6. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.
Reiman EM; Chen K; Caselli RJ; Alexander GE; Bandy D; Adamson JL; Lee W; Cannon A; Stephan EA; Stephan DA; Papassotiropoulos A
Neuroimage; 2008 Apr; 40(3):1214-21. PubMed ID: 18280754
[TBL] [Abstract][Full Text] [Related]
8. Atypical Localization and Dissociation between Glucose Uptake and Amyloid Deposition in Cognitively Normal APOE*E4 Homozygotic Elders Compared with Patients with Late-Onset Alzheimer's Disease.
Pardo JV; Lee JT;
eNeuro; 2018; 5(1):. PubMed ID: 29497704
[TBL] [Abstract][Full Text] [Related]
9. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOEepsilon4 carriers in the Australian population.
Rimajova M; Lenzo NP; Wu JS; Bates KA; Campbell A; Dhaliwal SS; McCarthy M; Rodrigues M; Paton A; Rowe C; Foster JK; Martins RN
J Alzheimers Dis; 2008 Mar; 13(2):137-46. PubMed ID: 18376055
[TBL] [Abstract][Full Text] [Related]
10. GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han.
Lin K; Tang M; Han H; Guo Y; Lin Y; Ma C
Neurol Sci; 2010 Jun; 31(3):277-81. PubMed ID: 19924507
[TBL] [Abstract][Full Text] [Related]
11. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
Ramirez-Lorca R; Boada M; Saez ME; Hernandez I; Mauleon A; Rosende-Roca M; Martinez-Lage P; Gutierrez M; Real LM; Lopez-Arrieta J; Gayan J; Antunez C; Gonzalez-Perez A; Tarraga L; Ruiz A
J Nutr Health Aging; 2009 Mar; 13(3):214-9. PubMed ID: 19262956
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.
Burns CM; Kaszniak AW; Chen K; Lee W; Bandy DJ; Caselli RJ; Reiman EM
J Alzheimers Dis; 2018; 62(2):833-840. PubMed ID: 29480176
[TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism and gray-matter concentration in apolipoprotein E ε4 positive normal subjects.
Samuraki M; Matsunari I; Chen WP; Shima K; Yanase D; Takeda N; Matsuda H; Yamada M
Neurobiol Aging; 2012 Oct; 33(10):2321-3. PubMed ID: 22188720
[TBL] [Abstract][Full Text] [Related]
14. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia.
Sleegers K; Bettens K; Brouwers N; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
Hum Mutat; 2009 Feb; 30(2):E338-44. PubMed ID: 18853460
[TBL] [Abstract][Full Text] [Related]
15. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
[TBL] [Abstract][Full Text] [Related]
16. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
[TBL] [Abstract][Full Text] [Related]
17. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes.
Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD;
Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545
[TBL] [Abstract][Full Text] [Related]
18. The synergistic risk effect of apolipoprotein ε4 and DNA (cytosine-5-)-methyltransferase 3 beta (DNMT3B) haplotype for Alzheimer's disease.
de Bem CM; Pezzi JC; Borba EM; Chaves ML; de Andrade FM; Fiegenbaum M; Camozzato A
Mol Biol Rep; 2016 Jul; 43(7):653-8. PubMed ID: 27188425
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
[TBL] [Abstract][Full Text] [Related]
20. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
